Improved dissolution of ibuprofen after crystallization from polymeric solution: Correlation with crystal parameter Scientific paper

Article Sidebar

Graphical Abstract
PDF (3.570 kB)
Published: Jun 29, 2021
DOI: https://doi.org/10.2298/JSC201209021N
Keywords:
steroidal anti inflammatory drug lattice strain dislocation density in vitro solubility

Main Article Content

Rudra Narayan Sahoo
School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar-751003, Odisha, India and Centurion University of Technology and Management, Odisha, India
https://orcid.org/0000-0001-6348-950X
Bhabani Sankar Satapathy
School of Pharmaceutical Sciences, Siksha O Anusandhan (Deemed to be University), Bhubaneswar-751003, Odisha, India
https://orcid.org/0000-0002-9175-8356
Subrata Mallick
School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to be University), Kalinganagar, Bhubaneswar-751003, Odisha, India
https://orcid.org/0000-0002-6606-1223

Abstract

The objective of the present work was to investigate the effect of various hydrophilic polymers, such as hydroxypropylmethyl cellulose, methyl cellulose, carboxymethyl cellulose and poly vinyl alcohol, on the in vitro dis­solution property of ibuprofen (IBU) crystallized from aqueous polymeric sol­utions. By using the solvent-change technique, IBU crystal products were pro­duced in the presence of the selected polymers. The results showed that in the presence of polymers, the crystallization yield of IBU was higher than that of pure drug crystals (absence of polymer). SEM photographs revealed visible changes in the crystal morphology in the presence of polymers. The FTIR spectra of the crystallized IBU (polymer-treated) showed a shift of the acid-
-dimer peak from 1718 to 1721 cm-1 but the absence of specific peaks for poly­mers. An XRD study further confirmed the absence of polymers in the crys­tal­lized IBU as no specific peaks were observed for the polymers. A higher per­centage of cumulative drug release was reported for the polymeric-treated IBU crystals than that of plain IBU. Further in vivo studies are warranted to estab­lish the in vitro–in vivo correlation for future technology transfer of the formul­ation.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Article Details

How to Cite
[1]
R. N. Sahoo, B. S. Satapathy, and S. Mallick, “Improved dissolution of ibuprofen after crystallization from polymeric solution: Correlation with crystal parameter: Scientific paper”, J. Serb. Chem. Soc., vol. 86, no. 6, pp. 571–584, Jun. 2021.
Issue
Vol. 86 No. 6 (2021)
Section
Physical Chemistry
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Creative Commons лиценца
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution license 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Read more....

Crossref
Scopus
Google Scholar
Europe PMC

References

D. B. Warren, H. Benameur, C. J. H. Porter, C. W. Pouton, J. Drug Target. 18 (2010) 704 (https://doi.org/10.3109/1061186X.2010.525652)

R. Thakuria, A. Delori, W. Jones, M. P. Lipert, L. Roy, N. Rodriguez-Hornedo, Int. J. Pharm. 453 (2013) 101(https://doi.org/10.1016/j.ijpharm.2012.10.043)

A. M. Pherson, B. Cudney, Acta Cryst., F 70 (2014) 1445. (https://doi.org/10.1107/S2053230X14019670)

N. R. Hornedo, D. Murphy, J. Pharm. Sci. 88 (1999) 651 (https://doi.org/10.1021/js980490h)

K. Kachrimanis, S. Malamataris, J. Pharm. Pharmacol. 51 (1999) 1219 (https://doi.org/10.1211/0022357991776949)

R. Bushra, N. Aslam, Oman Med. J. 25 (2010) 155 (https://doi.org/10.5001/omj.2010.49)

O. C. Larbi, H. Merine, Y. Ramli, F. B. Toumi, K. Guemra, A. Dehbi, J. Serb. Chem. Soc. 83 (2018) 1243 (https://doi.org/10.2298/JSC171112065LA)

B. J. Orlando, M. J. Lucido, M. G. Malkowsk, J. Struct. Biol. 189 (2015) 62 (https://doi.org/10.1016/j.jsb.2014.11.005)

S. Mallick, S. Pattnaik, K. Swain, P. K. De, A. Saha, G. Ghoshal, A. Mondal, Eur. J. Pharm. Biopharm. 68 (2008) 346 (https://doi.org/10.1016/j.ejpb.2007.06.003)

S. Mallick, S. Pattnaik, K. Swain, P. K. De, A. Saha, P. Mazumdar, G. Ghoshal., Drug Dev. Ind. Pharm. 34 (2008) 726 (https://doi.org/10.1080/03639040801901868)

H. H. Baek, D. H. Kim, S. Y. Kwon, S. J. Rho, D. W. Kim, H. G. Choi, Y.R. Kim, C. S. Yong, Arch. Pharm. Res. 35 (2012) 683 (https://doi.org/10.1007/s12272-012-0412-4)

M. Newa, K. H. Bhandari, D. X. Li, T. H. Kwon, J. A. Kim, B. K. Yoo, J. S. Woo, W. S. Lyoo, C. S. Yong, H. G. Choi. Int. J. Pharm. 343 (2007) 228 (https://doi.org/10.1016/j.ijpharm.2007.05.031)

Z. Emire, E. Yabalak, O. Görmez, A. Gizir, J. Serb. Chem. Soc. 82 (2017) 99 (https://doi.org/10.2298/JSC160520079E)

Y. Yuliandra, E. Zaini, S. Syofyan, W. Pratiwi, L. N. Putri, Y. S. Pratiwi, H. Arifin, Sci. Pharm. 86 (2018) 1 (https://doi.org/10.3390/scipharm86020023)

A. Hussain, G. Smith, K. A. Khan, N. I. Bukhari, N. I. Pedge, I. Ermolina, Eur J. Pharm.Sci. 123 (2018) 395 (https://doi.org/10.1016/j.ejps.2018.08.001)

S. Mallick, P. K Dey, S. Sannigrahi, A. Mitra, Acta Pol. Pharm. 61 (2004) 447

R. N. Sahoo, A. Nanda, A. Pramanik, S. Nandi, R. Swain, S. K. Pradhan, S. Mallick, Acta Chim. Slov. 66 (2019) 1 (https://doi.org/10.17344/acsi.2019.5139)

T. S. Latha, M. C. Reddy, V.D. Prasad, S. V. Muthukonda, D. Lomada, Ind. J. Pharmacol. 49 (2017) 458 (https://doi.org/10.4103/ijp.IJP_536_16)

M. Acharya, S. Mishra, R. N. Sahoo, S. Mallick, Acta Chim. Slov. 64 (2017) 45 (https://doi.org/10.17344/acsi.2016.2772)

J. Pi, S. Wang, W. Li, D. Kebebe, Y. Zhang, B. Zhang, Asian J. Pharm. Sci. 14 (2019) 154 (https://doi.org/10.1016/j.ajps.2018.04.009)

Y. Lu, S. Kim, K. Park, Int. J. Pharm. 418 (2011) 142 (https://doi.org/10.1016/j.ijpharm.2011.01.010)

F. Kesisoglou, A. Hermans, C. Neu, K. L. Yee, J. Palcza, J. Miller, J. Pharm. Sci. 104 (2015) 2913 (https://doi.org/10.1002/jps.24362)

P. Arya, K. Pathak. Int. J. Pharm. 460 (2014) 1 (https://doi.org/10.1016/j.ijpharm.2013.10.045)

F. L. Mota, A. P. Carneiro, A. J. Queimada, S. P. Pinho, E. A. Macedo. Eur. J. Pharm. Sci. 37 (2009) 499 (https://doi.org/10.1016/j.ejps.2009.04.009)

F. A. Maulvi, S. J. Dalwadi, V. T. Thakkar, T. G. Soni, M. C. Gohel, T. R. Gandhi. Powder Technol. 207 (2011) 47 (https://doi.org/10.1016/j.powtec.2010.10.009)

L. Hu, J. Yang, W. Liu, L. Li, Drug Deliv. 18 (2011) 90 (https://doi.org/10.3109/10717544.2010.522613)

B. S. Satapathy, A. Patel, R. N. Sahoo, S. Mallick, J. Serb. Chem. Soc. 86 (2021) 5 (https://doi.org/10.2298/JSC200705049S)

L. Xu, S. M. Li, H. Sunada, Q. F. Wang, J. Drug Deliv. Sci. Technol. 17 (2007) 145 (https://doi.org/10.1016/S1773-2247(07)50022-5)

L. Xu, S. M. Li, Y. Wang, M. Wei, H. M. Yao, H. Sunada, J. Drug Deliv. Sci. Technol. 19 (2009) 113 (https://doi.org/10.1016/S1773-2247(09)50018-4)

M. Aroso, J. C. Silva, F. Mano, A. S. Ferreira, M. Dionísio, I. Sá-Nogueira, S. Barreiros, R. L. Reis, A. Paiva, A. R. Duarte, Eur. J. Pharm. Biopharm. 98 (2016) 57 (https://doi.org/10.1016/j.ejpb.2015.11.002)

M. M. Santos, L. R. Raposo, G. V. Carrera, A. Costa, M. Dionísio, P. V. Baptista, A. R. Fernandes, L. C. Branco, Chem. Med. Chem. 14 (2019) 907 (https://doi.org/10.1002/cmdc.201900040)

H. Stevens, M. Voelker, L. Gow, F. MacDougall, G. Bieri, J. Drug Deliv. Sci. Technol. 51 (2019) 535 (https://doi.org/10.1016/j.jddst.2019.02.027)

M. Alemanni, S. C. Gatoulis, M. Voelker, Minerva Med. 107 (2016) 125 (https://www.minervamedica.it/en/journals/minerva-medica/article.php?cod=R10Y2016N03A0125)

A. Avdeef, ADMET DMPK 2 (2014) 33. (https://doi.org/10.5599/admet.2.1.30).

Most read articles by the same author(s)